Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1996 Oct;34(10):2432–2434. doi: 10.1128/jcm.34.10.2432-2434.1996

Encephalopathy associated with enteroinvasive Escherichia coli 0144:NM infection.

M Ephros 1, D Cohen 1, M Yavzori 1, N Rotman 1, B Novic 1, S Ashkenazi 1
PMCID: PMC229287  PMID: 8880494

Abstract

Central nervous system manifestations typically occur with Shigella gastroenteritis and also in enteric Salmonella and Campylobacter infections. To date no association between enteroinvasive Escherichia coli infection and neurologic symptoms has been described. Two children with diarrhea caused by E. coli 0144:NM had otherwise unexplained encephalopathy manifested by profound stupor in one child and by obtundation and meningismus in the other one. These cases of infection occurred in northern Israel during a period of an unusually high rate of enteric infection caused by this organism. None of the microbiologic properties studied were uniquely attributable to the encephalopathic cases. The two encephalopathic as well as all eight nonencephalopathic isolates studied possessed the 140-MDa invasive plasmid. All 10 isolates examined produced small amounts of cytotoxin by the HeLa cell assay, all were nonmotile, and all had identical antibiograms. Eight of 10 of the isolates had identical plasmid profiles, while 2 isolates (from nonencephalopathic patients) had slightly different plasmid profiles. This is the first report of encephalopathy associated with enteroinvasive E. coli.

Full Text

The Full Text of this article is available as a PDF (160.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashkenazi S., Bellah G., Cleary T. G. Hallucinations as an initial manifestation of childhood shigellosis. J Pediatr. 1989 Jan;114(1):95–96. doi: 10.1016/s0022-3476(89)80610-9. [DOI] [PubMed] [Google Scholar]
  2. Ashkenazi S., Cleary K. R., Pickering L. K., Murray B. E., Cleary T. G. The association of Shiga toxin and other cytotoxins with the neurologic manifestations of shigellosis. J Infect Dis. 1990 May;161(5):961–965. doi: 10.1093/infdis/161.5.961. [DOI] [PubMed] [Google Scholar]
  3. Ashkenazi S., Yuhas Y., Even-Tov S., Kaminsky E., Danon Y. L. The effect of shiga toxin and sonicates of Shigella isolates from children with neurologic manifestation on neuroblastoma cell lines. Isr J Med Sci. 1994 Aug;30(8):604–610. [PubMed] [Google Scholar]
  4. Barrett-Connor E., Connor J. D. Extraintestinal manifestations of shigellosis. Am J Gastroenterol. 1970 Mar;53(3):234–245. [PubMed] [Google Scholar]
  5. Birnboim H. C., Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 1979 Nov 24;7(6):1513–1523. doi: 10.1093/nar/7.6.1513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Goren A., Freier S., Passwell J. H. Lethal toxic encephalopathy due to childhood shigellosis in a developed country. Pediatrics. 1992 Jun;89(6 Pt 2):1189–1193. [PubMed] [Google Scholar]
  7. Hale T. L., Sansonetti P. J., Schad P. A., Austin S., Formal S. B. Characterization of virulence plasmids and plasmid-associated outer membrane proteins in Shigella flexneri, Shigella sonnei, and Escherichia coli. Infect Immun. 1983 Apr;40(1):340–350. doi: 10.1128/iai.40.1.340-350.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Harris J. R., Wachsmuth I. K., Davis B. R., Cohen M. L. High-molecular-weight plasmid correlates with Escherichia coli enteroinvasiveness. Infect Immun. 1982 Sep;37(3):1295–1298. doi: 10.1128/iai.37.3.1295-1298.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Mulligan K., Nelson S., Friedman H. S., Andrews P. I. Shigellosis-associated encephalopathy. Pediatr Infect Dis J. 1992 Oct;11(10):889–890. doi: 10.1097/00006454-199210000-00017. [DOI] [PubMed] [Google Scholar]
  10. Perles Z., Bar-Ziv J., Granot E. Brain edema: an underdiagnosed complication of Shigella infection. Pediatr Infect Dis J. 1995 Dec;14(12):1114–1115. [PubMed] [Google Scholar]
  11. Sandyk R., Brennan M. J. Fulminating encephalopathy associated with Shigella flexneri infection. Arch Dis Child. 1983 Jan;58(1):70–71. doi: 10.1136/adc.58.1.70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Sethabutr O., Venkatesan M., Murphy G. S., Eampokalap B., Hoge C. W., Echeverria P. Detection of Shigellae and enteroinvasive Escherichia coli by amplification of the invasion plasmid antigen H DNA sequence in patients with dysentery. J Infect Dis. 1993 Feb;167(2):458–461. doi: 10.1093/infdis/167.2.458. [DOI] [PubMed] [Google Scholar]
  13. Wiley R. G., Donohue-Rolfe A., Keusch G. T. Axonally transported Shigella cytotoxin is neuronotoxic. J Neuropathol Exp Neurol. 1985 Sep;44(5):496–506. doi: 10.1097/00005072-198509000-00005. [DOI] [PubMed] [Google Scholar]
  14. Yavzori M., Cohen D., Bercovier H. Molecular epidemiology of Shigella infections in Israel. Epidemiol Infect. 1992 Oct;109(2):273–282. doi: 10.1017/s0950268800050226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Yavzori M., Cohen D., Wasserlauf R., Ambar R., Rechavi G., Ashkenazi S. Identification of Shigella species in stool specimens by DNA amplification of different loci of the Shigella virulence plasmid. Eur J Clin Microbiol Infect Dis. 1994 Mar;13(3):232–237. doi: 10.1007/BF01974542. [DOI] [PubMed] [Google Scholar]
  16. Yuhas Y., Weizman A., Dinari G., Ashkenazi S. An animal model for the study of neurotoxicity of bacterial products and application of the model to demonstrate that Shiga toxin and lipopolysaccharide cooperate in inducing neurologic disorders. J Infect Dis. 1995 May;171(5):1244–1249. doi: 10.1093/infdis/171.5.1244. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES